Santa Clara, CA – According to filings with the U.S. Securities and Exchange Commission, Cardiva Medical is raising $44,999,983.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Charles Maroney played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Cardiva Medical

Cardiva Medical, Inc. designs and develops vascular access management products that facilitate rapid hemostasis following diagnostic and interventional endovascular procedures. Since its founding, Cardiva has introduced a series of advanced vascular access management technologies designed to help the body heal itself. Cardiva Medical, Inc. is a privately-held company funded by leading venture capital investors, including PTV Healthcare Capital, Canepa Healthcare LLC, Amkey Ventures LLC and Luther King Capital Management.

To learn more about Cardiva Medical, visit http://www.cardivamedical.com/

Contact:
Charles Maroney, President and Chief Executive Officer
408-470-7170
charles_maroney@cardivamedical.com

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved